ZBNA
CRL icon

Zions Bancorporation, National Association’s Charles River Laboratories CRL Stock Holding History

Zions Bancorporation, National Association’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$624K Sell
2,753
-2,722
-50% -$485K 0.04% 219
2026
Q1 		$944K Sell
5,475
-4,037
-42% -$748K 0.06% 175
2025
Q4 		$1.9M Sell
9,512
-624
-6% -$113K 0.09% 154
2025
Q3 		$1.59M Sell
10,136
-1,386
-12% -$220K 0.08% 171
2025
Q2 		$1.75M Buy
11,522
+969
+9% +$129K 0.09% 180
2025
Q1 		$1.59M Buy
+10,553
New +$1.77M 0.1% 174

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Zions Bancorporation, National Association's CRL Position: Q2 2026 in Review

Zions Bancorporation, National Association reduced its Charles River Laboratories (CRL) stake by 50% in Q2 2026, selling an estimated $485K and leaving 2,753 shares worth $624K. The position accounts for 0.04% of the portfolio, ranked #219.

Zions Bancorporation, National Association first reported a position in CRL in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.9M in Q4 2025. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Zions Bancorporation, National Association held 2,753 shares of Charles River Laboratories worth $624K as of Q2 2026.
  • Zions Bancorporation, National Association sold 2,722 Charles River Laboratories shares in Q2 2026, an estimated $485K.
  • Charles River Laboratories made up 0.04% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #219 holding.
  • Zions Bancorporation, National Association first reported a position in Charles River Laboratories in Q1 2025 and has held it in 6 quarters since.
  • Zions Bancorporation, National Association's Charles River Laboratories position peaked at $1.9M in Q4 2025.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.